[1]
Elgasim, M.A.E.A., Suleiman, Y., Ahmed ELmubark, E.M.E., Abdalmahmoud, A.A.A., Babkeir, S.A.M., Omer, R., Yasin, R., Abaker, K.E.A., Babker, R.O.A., Alryah, A. and Alzain, T. 2019. Benefits of Docetaxel for Metastatic Castration-Resistant Prostate Cancer Sudanese Patients and the Effective Number of Cycle and Dose (2013–2017). International Research Journal of Oncology. 2, 2 (Jul. 2019), 1-9.